Bloom Energy stock price slides as Jefferies lifts target but keeps Underperform
26 January 2026
1 min read

Bloom Energy stock price slides as Jefferies lifts target but keeps Underperform

New York, Jan 26, 2026, 15:29 ET — Regular session

  • Bloom Energy shares slipped roughly 4% in afternoon trading, hovering close to the session’s low
  • Jefferies bumps up its price target yet sticks with an Underperform rating
  • Investors are zeroing in on the Feb. 5 results, searching for clues on delivery pace and capacity.

Shares of Bloom Energy Corporation (NYSE: BE) slid roughly 4.3% to $138.72 in afternoon trading Monday, after earlier fluctuating between $147.60 and $138.17.

The drop matters because Bloom has turned into a quick gauge for a broader trend: data centers demanding power immediately, not down the road. As its next earnings approach, traders are taking every analyst update as a sign of how much positive news is already priced in.

Bloom’s recent surge raises a straightforward question once again. Can it produce enough systems at scale, on time, while maintaining price and margin discipline?

Jefferies raised its price target on Bloom Energy to $92 from $53 but maintained an Underperform rating. Analyst Dushyant Ailani attributed the jump to updated 2026 forecasts tied to recent orders involving American Electric Power and Quanta. He warned, however, that “peak valuations leave little room for error” ahead of the company’s earnings report in about 10 days, when investors will be watching closely for any capacity-expansion updates. 1

The split screen — rising numbers paired with a still-bearish rating — keeps appearing in coverage as Bloom’s shares climb. Bulls argue that on-site generation could shorten the long wait for new grid hookups; bears remain focused on execution risks and the pace at which production can truly scale.

Bloom offers solid oxide fuel-cell systems that produce electricity on site, usually powered by natural gas or other fuels. The company’s key selling points are reliability and rapid deployment, targeting energy-intensive data centers.

Investors will be looking for the next update to clarify what “capacity” represents in concrete terms—and what impact it has on cash flow. Attention will also focus on how management explains turning sizable orders into actual deployments, and how uneven that rollout might be from one quarter to the next.

However, the situation is double-edged. Should management take a conservative stance on 2026 delivery goals or indicate increased spending to handle demand, the stock’s recent swings could flip just as fast.

Bloom announced it will report its fourth-quarter 2025 earnings after the market closes on Feb. 5. The company plans a conference call at 5:00 p.m. ET. 2

For now, trading will hinge on headlines — analyst updates, moves from major clients, and hints about manufacturing growth. The next key milestone is the Feb. 5 report and the guidance it brings.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
UMC stock jumps in New York ahead of earnings; what investors watch next
Previous Story

UMC stock jumps in New York ahead of earnings; what investors watch next

Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play
Next Story

Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play

Go toTop